Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT

被引:7
作者
Maldonado, Angela [1 ,2 ]
机构
[1] Providence Sacred Heart Med Ctr, Kidney Transplant Program, Spokane, WA USA
[2] Washington State Univ, Dept Pharmacotherapy, Spokane, WA USA
关键词
TISSUE-PLASMINOGEN ACTIVATOR; HEPARIN;
D O I
10.1002/ajh.21367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:251 / 253
页数:3
相关论文
共 13 条
[1]   Effect of renal function on the pharmacodynamics of argatroban [J].
Arpino, PA ;
Hallisey, RK .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) :25-29
[2]   Comparison of argatroban and hirudin for the reperfusion of thrombotic arterial occlusion by tissue plasminogen activator [J].
Boeve, TJ ;
Reed, GL ;
de Oliveira, NC ;
Titus, J ;
Janssens, S ;
Giugliano, RP ;
Torchiana, D ;
Daggett, W ;
Schwarz, R ;
Jang, IK .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1998, 6 (02) :103-108
[3]  
*GEN INC, 2001, CATHLL ACT ALT PACK
[4]  
Hirsh J, 2008, CHEST, V134, P473
[5]  
Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652
[6]   Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: A case study [J].
LaMonte, MP ;
Stallmeyer, MJB .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2004, 17 (02) :151-156
[7]  
Serebruany, 1998, J Thromb Thrombolysis, V5, P49
[8]   Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia [J].
Turba, Ulku C. ;
Bozlar, Ugur ;
Simsek, Serkan .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (07) :1046-1050
[9]   USE OF A DIRECT THROMBIN INHIBITOR (ARGATROBAN) DURING PULSE-SPRAY THROMBOLYSIS IN EXPERIMENTAL THROMBOSIS [J].
VALJI, K ;
ARUN, K ;
BOOKSTEIN, JJ .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (01) :91-95
[10]   Direct Antithrombins - Mechanisms, trials, and role in contemporary interventional medicine [J].
Wong, Cheuk-Kit ;
White, Harvey D. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (04) :249-257